{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T14:24:26Z","timestamp":1794493466539,"version":"4.9.1"},"reference-count":39,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T00:00:00Z","timestamp":1668729600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004348","name":"Stockholms L\u00e4ns Landsting","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004348","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007232","name":"Radiumhemmets Forskningsfonder","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007232","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002794","name":"Cancerfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.jhep.2022.11.011","type":"journal-article","created":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T21:12:19Z","timestamp":1668805939000},"page":"604-613","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":76,"title":["Prospective surveillance for cholangiocarcinoma in unselected individuals with primary sclerosing cholangitis"],"prefix":"10.1016","volume":"78","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4696-0931","authenticated-orcid":false,"given":"Christina","family":"Villard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingalill","family":"Friis-Liby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fredrik","family":"Rorsman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karouk","family":"Said","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5691-2127","authenticated-orcid":false,"given":"Anna","family":"Warnqvist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7981-0927","authenticated-orcid":false,"given":"Martin","family":"Cornillet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7614-739X","authenticated-orcid":false,"given":"Stergios","family":"Kechagias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0942-0816","authenticated-orcid":false,"given":"Nils","family":"Nyhlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e5rten","family":"Werner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Izabella","family":"Janczewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Therese","family":"Hagstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0586-8063","authenticated-orcid":false,"given":"Emma","family":"Nilsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annika","family":"Bergquist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.jhep.2022.11.011_bib1","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1002\/hep.26565","article-title":"Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis","volume":"58","author":"Boonstra","year":"2013","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.jhep.2022.11.011_bib2","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0168-8278(01)00288-4","article-title":"Hepatic and extrahepatic malignancies in primary sclerosing cholangitis","volume":"36","author":"Bergquist","year":"2002","journal-title":"J\u00a0Hepatol"},{"issue":"8","key":"10.1016\/j.jhep.2022.11.011_bib3","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1053\/j.gastro.2017.02.038","article-title":"Patient age, sex, and inflammatory bowel disease phenotype associate with course of primary sclerosing cholangitis","volume":"152","author":"Weismuller","year":"2017","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.jhep.2022.11.011_bib4","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.jhep.2021.12.010","article-title":"Cholangiocarcinoma landscape in Europe: diagnostic, prognostic and therapeutic insights from the ENSCCA Registry","volume":"76","author":"Izquierdo-Sanchez","year":"2022","journal-title":"J\u00a0Hepatol"},{"issue":"8","key":"10.1016\/j.jhep.2022.11.011_bib5","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/hpb.12450","article-title":"Hilar cholangiocarcinoma: expert consensus statement","volume":"17","author":"Mansour","year":"2015","journal-title":"HPB (Oxford)"},{"issue":"8","key":"10.1016\/j.jhep.2022.11.011_bib6","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/hpb.12441","article-title":"Intrahepatic cholangiocarcinoma: expert consensus statement","volume":"17","author":"Weber","year":"2015","journal-title":"HPB (Oxford)"},{"issue":"12","key":"10.1016\/j.jhep.2022.11.011_bib7","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1016\/j.cgh.2019.07.011","article-title":"AGA clinical practice update on surveillance for hepatobiliary cancers in patients with primary sclerosing cholangitis: expert review","volume":"17","author":"Bowlus","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.jhep.2022.11.011_bib8","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1053\/j.gastro.2020.05.049","article-title":"Effects of primary sclerosing cholangitis on risks of cancer and death in people with inflammatory bowel disease, based on sex, race, and age","volume":"159","author":"Trivedi","year":"2020","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.jhep.2022.11.011_bib9","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1002\/hep.29730","article-title":"Surveillance for hepatobiliary cancers in patients with primary sclerosing cholangitis","volume":"67","author":"Ali","year":"2018","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.jhep.2022.11.011_bib10","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1002\/hep.29293","article-title":"Recommendations on the use of magnetic resonance imaging in PSC-A position statement from the International PSC Study Group","volume":"66","author":"Schramm","year":"2017","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.jhep.2022.11.011_bib11","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1002\/hep.22441","article-title":"Utility of serum tumor markers, imaging, and biliary cytology for detecting cholangiocarcinoma in primary sclerosing cholangitis","volume":"48","author":"Charatcharoenwitthaya","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2022.11.011_bib12","article-title":"Impact on follow-up strategies in patients with primary sclerosing cholangitis","author":"Bergquist","year":"2022","journal-title":"Liver Int"},{"issue":"12","key":"10.1016\/j.jhep.2022.11.011_bib13","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1007\/s00261-017-1328-8","article-title":"Cholangiocarcinoma and its mimickers in primary sclerosing cholangitis","volume":"42","author":"Lee","year":"2017","journal-title":"Abdom Radiol (NY)"},{"issue":"9","key":"10.1016\/j.jhep.2022.11.011_bib14","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1111\/j.1572-0241.2004.30281.x","article-title":"A\u00a0comparison of routine cytology and fluorescence in situ hybridization for the detection of malignant bile duct strictures","volume":"99","author":"Kipp","year":"2004","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"10.1016\/j.jhep.2022.11.011_bib15","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1080\/00365521.2016.1263681","article-title":"Clinical implications of serial versus isolated biliary fluorescence in situ hybridization (FISH) polysomy in primary sclerosing cholangitis","volume":"52","author":"Quinn","year":"2017","journal-title":"Scand J Gastroenterol"},{"issue":"1","key":"10.1016\/j.jhep.2022.11.011_bib16","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1080\/00365521.2017.1385840","article-title":"Optimizing the detection of biliary dysplasia in primary sclerosing cholangitis before liver transplantation","volume":"53","author":"Majeed","year":"2018","journal-title":"Scand J Gastroenterol"},{"issue":"1","key":"10.1016\/j.jhep.2022.11.011_bib17","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/liv.12640","article-title":"Primary sclerosing cholangitis increases the risk for pancreatitis after endoscopic retrograde cholangiopancreatography","volume":"35","author":"von Seth","year":"2015","journal-title":"Liver Int"},{"issue":"5","key":"10.1016\/j.jhep.2022.11.011_bib18","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1002\/hep.24570","article-title":"Cancer surveillance in patients with primary sclerosing cholangitis","volume":"54","author":"Razumilava","year":"2011","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.jhep.2022.11.011_bib19","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1002\/hep.31575","article-title":"Early cholangiocarcinoma detection with magnetic resonance imaging versus ultrasound in primary sclerosing cholangitis","volume":"73","author":"Eaton","year":"2021","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.jhep.2022.11.011_bib20","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1136\/gutjnl-2018-317993","article-title":"British Society of Gastroenterology and UK-PSC guidelines for the diagnosis and management of primary sclerosing cholangitis","volume":"68","author":"Chapman","year":"2019","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.jhep.2022.11.011_bib21","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1093\/ecco-jcc\/jjy113","article-title":"ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: initial diagnosis, monitoring of known IBD, detection of complications","volume":"13","author":"Maaser","year":"2019","journal-title":"J\u00a0Crohns Colitis"},{"issue":"2","key":"10.1016\/j.jhep.2022.11.011_bib22","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jhep.2009.04.009","article-title":"EASL Clinical Practice Guidelines: management of cholestatic liver diseases","volume":"51","author":"European Association for the Study of the","year":"2009","journal-title":"J\u00a0Hepatol"},{"issue":"Suppl 6","key":"10.1016\/j.jhep.2022.11.011_bib23","first-page":"VI1","article-title":"Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document","volume":"51","author":"Khan","year":"2002","journal-title":"Gut"},{"issue":"6","key":"10.1016\/j.jhep.2022.11.011_bib24","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1055\/s-0043-107029","article-title":"Role of endoscopy in primary sclerosing cholangitis: European society of gastrointestinal endoscopy (ESGE) and European association for the study of the liver (EASL) clinical guideline","volume":"49","author":"Aabakken","year":"2017","journal-title":"Endoscopy"},{"issue":"2","key":"10.1016\/j.jhep.2022.11.011_bib25","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/liv.14007","article-title":"Diagnostic performance of a stepwise cytological algorithm for biliary malignancy in primary sclerosing cholangitis","volume":"39","author":"von Seth","year":"2019","journal-title":"Liver Int"},{"issue":"5","key":"10.1016\/j.jhep.2022.11.011_bib26","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1001\/jamasurg.2013.1221","article-title":"The Swedish registry of gallstone surgery and endoscopic retrograde cholangiopancreatography (GallRiks): a nationwide registry for quality assurance of gallstone surgery","volume":"148","author":"Enochsson","year":"2013","journal-title":"JAMA Surg"},{"issue":"7","key":"10.1016\/j.jhep.2022.11.011_bib27","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/j.1477-2574.2011.00330.x","article-title":"A\u00a0standard definition of major hepatectomy: resection of four or more liver segments","volume":"13","author":"Reddy","year":"2011","journal-title":"HPB (Oxford)"},{"issue":"2","key":"10.1016\/j.jhep.2022.11.011_bib28","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1055\/s-2004-828896","article-title":"Liver transplantation for unresectable perihilar cholangiocarcinoma","volume":"24","author":"Heimbach","year":"2004","journal-title":"Semin Liver Dis"},{"issue":"9","key":"10.1016\/j.jhep.2022.11.011_bib29","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1097\/MEG.0b013e3283554bbf","article-title":"Cholangiocarcinoma and dominant strictures in patients with primary sclerosing cholangitis: a 25-year single-centre experience","volume":"24","author":"Chapman","year":"2012","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.jhep.2022.11.011_bib30","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jhep.2009.01.023","article-title":"Influence of dominant bile duct stenoses and biliary infections on outcome in primary sclerosing cholangitis","volume":"51","author":"Rudolph","year":"2009","journal-title":"J\u00a0Hepatol"},{"issue":"9","key":"10.1016\/j.jhep.2022.11.011_bib31","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1007\/s10620-005-2927-8","article-title":"The value of serum CA 19-9 in predicting cholangiocarcinomas in patients with primary sclerosing cholangitis","volume":"50","author":"Levy","year":"2005","journal-title":"Dig Dis Sci"},{"issue":"4","key":"10.1016\/j.jhep.2022.11.011_bib32","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S0168-8278(99)80198-6","article-title":"A\u00a03-year prospective study on serum tumor markers used for detecting cholangiocarcinoma in patients with primary sclerosing cholangitis","volume":"30","author":"Hultcrantz","year":"1999","journal-title":"J\u00a0Hepatol"},{"issue":"6","key":"10.1016\/j.jhep.2022.11.011_bib33","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1111\/apt.15146","article-title":"Longitudinal analysis of CA19-9 reveals individualised normal range and early changes before development of biliary tract cancer in patients with primary sclerosing cholangitis","volume":"49","author":"Wannhoff","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.jhep.2022.11.011_bib34","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1097\/SLA.0000000000002574","article-title":"Transplantation versus resection for hilar cholangiocarcinoma: an argument for shifting treatment paradigms for resectable disease","volume":"267","author":"Ethun","year":"2018","journal-title":"Ann Surg"},{"issue":"5","key":"10.1016\/j.jhep.2022.11.011_bib35","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1111\/liv.13276","article-title":"Value of brush cytology for optimal timing of liver transplantation in primary sclerosing cholangitis","volume":"37","author":"Vannas","year":"2017","journal-title":"Liver Int"},{"issue":"33","key":"10.1016\/j.jhep.2022.11.011_bib36","doi-asserted-by":"crossref","first-page":"6147","DOI":"10.3748\/wjg.v23.i33.6147","article-title":"Suspicious brush cytology is an indication for liver transplantation evaluation in primary sclerosing cholangitis","volume":"23","author":"Boyd","year":"2017","journal-title":"World J Gastroenterol"},{"issue":"1","key":"10.1016\/j.jhep.2022.11.011_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3748\/wjg.v18.i1.1","article-title":"Recurrence and rejection in liver transplantation for primary sclerosing cholangitis","volume":"18","author":"Fosby","year":"2012","journal-title":"World J Gastroenterol"},{"issue":"2","key":"10.1016\/j.jhep.2022.11.011_bib38","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/apt.14797","article-title":"Follow-up magnetic resonance imaging\/3D-magnetic resonance cholangiopancreatography in patients with primary sclerosing cholangitis: challenging for experts to interpret","volume":"48","author":"Zenouzi","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.jhep.2022.11.011_bib39","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1007\/s00330-021-08147-7","article-title":"Reporting standards for primary sclerosing cholangitis using MRI and MR cholangiopancreatography: guidelines from MR working group of the international primary sclerosing cholangitis study group","volume":"32","author":"Venkatesh","year":"2022","journal-title":"Eur Radiol"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827822033037?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827822033037?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:47:30Z","timestamp":1759175250000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827822033037"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S0168827822033037"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2022.11.011","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prospective surveillance for cholangiocarcinoma in unselected individuals with primary sclerosing cholangitis","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2022.11.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier B.V. on behalf of European Association for the Study of the Liver.","name":"copyright","label":"Copyright"}]}}